Under the partnership, the companies aim to bring access to international clinical studies for patients, physicians as well as healthcare institutions and new treatments quicker to patients by accelerating trial recruitment.
With support from Sigmasoft, Clinerion will integrate healthcare institutions and physicians in its international Patient Network Explorer platform and expand clinical research opportunities for patients in Greece and Cyprus.
With the platform, trial sponsors can easily bring their trials to patients, accelerating the path to market for new treatments.
Sigmasoft CEO and founder Georgios Stefanidis said: “We are very pleased to partner with Clinerion and assist in more effective clinical research in Greece and Cyprus.
“We are looking forward in integrating more healthcare institutions across Greece and Cyprus in the Patient Network Explorer platform, as well as providing real world evidence data, based on our existing customer base of physicians nationwide.”
Sigmasoft’s e-prescribing and electronic medical record (EHR)-based medical software MedExpress is fully interoperable with the Greek National ePrescribing System.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMore than 3,500 physicians are currently using the software in medical practices, hospitals, clinics, primary care centres and healthcare institutions across Greece.
Clinerion CEO Ian Rentsch said: “Sigmasoft is the advanced technology partner we need to improve patient lives in Greece and Cyprus.
“Patients are our first priority. We are committed to the early detection, prevention and finding cures for all chronic and acute diseases using our homegrown patented digital technology.”